SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001171843-16-011750
Filing Date
2016-08-12
Accepted
2016-08-12 17:26:17
Documents
41
Period of Report
2016-06-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q f10q_081216p.htm 10-Q 271525
2 EXHIBIT 31.1 exh_311.htm EX-31.1 8035
3 EXHIBIT 31.2 exh_312.htm EX-31.2 8238
4 EXHIBIT 32.1 exh_321.htm EX-32.1 5683
  Complete submission text file 0001171843-16-011750.txt   1845059

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE FILE xbit-20160630.xml EX-101.INS 267666
6 XBRL SCHEMA FILE xbit-20160630.xsd EX-101.SCH 22733
7 XBRL CALCULATION FILE xbit-20160630_cal.xml EX-101.CAL 20352
8 XBRL DEFINITION FILE xbit-20160630_def.xml EX-101.DEF 166795
9 XBRL LABEL FILE xbit-20160630_lab.xml EX-101.LAB 154307
10 XBRL PRESENTATION FILE xbit-20160630_pre.xml EX-101.PRE 179957
Mailing Address 8201 E. RIVERSIDE DRIVE BUILDING 4, SUITE 100 AUSTIN TX 78744
Business Address 8201 E. RIVERSIDE DRIVE BUILDING 4, SUITE 100 AUSTIN TX 78744 512-386-2930
XBiotech Inc. (Filer) CIK: 0001626878 (see all company filings)

IRS No.: 000000000 | State of Incorp.: A1 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-37347 | Film No.: 161829250
SIC: 2834 Pharmaceutical Preparations